Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fortress Biotech (FBIO) Return on Capital Employed (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Return on Capital Employed data on record, last reported at 0.77% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 84.0% year-over-year to 0.77%; the TTM value through Sep 2025 reached 0.77%, up 84.0%, while the annual FY2024 figure was 1.31%, 33.0% down from the prior year.
  • Return on Capital Employed reached 0.77% in Q3 2025 per FBIO's latest filing, up from 0.94% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.33% in Q1 2021 and bottomed at 2.29% in Q2 2023.
  • Average Return on Capital Employed over 5 years is 1.08%, with a median of 1.1% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: crashed -76bps in 2023, then surged 106bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.61% in 2021, then plummeted by -83bps to 1.12% in 2022, then plummeted by -104bps to 2.29% in 2023, then grew by 25bps to 1.72% in 2024, then skyrocketed by 55bps to 0.77% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.77% in Q3 2025, 0.94% in Q2 2025, and 1.1% in Q1 2025.